Literature DB >> 11892044

The molecular biology of nasal polyposis.

J M Bernstein1.   

Abstract

The molecular biologic events in the development of nasal polyps are now becoming unraveled. It appears that eosinophils are the dominant inflammatory cell present in this tissue. The events leading up to the extravasation of eosinophils into the lamina propria nasal polyps are regulated by the proinflammatory cytokines tumor necrosis factor-alpha and interleukin-1 beta. These cytokines upregulate very late antigen-4 on the surface of eosinophils and vascular cell adhesion molecule-1 on the surface of the endothelial blood vessel. Chemokines such as RANTES (regulated upon activation, normal T-cell expressed and secreted) and eotaxin are responsible for the movement of eosinophils into the lamina propria of the nasal polyp. The release of major basic protein has an effect on alteration of the epithelial architecture and on the sodium and chloride flux into and out of the apical epithelial cell of the tissue. Finally, the alteration of the surface epithelium results in a defect in the migration of the cystic fibrosis transmembrane regulator protein to the apical surface. These two events, the release of major basic protein from the eosinophil and the alteration of the architecture of the surface epithelium, lead to an increase in sodium absorption and resultant edema: the hallmark of the pathology of the nasal polyp.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11892044     DOI: 10.1007/s11882-001-0017-3

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.919


  17 in total

1.  Effects of short-term nitrogen monoxide inhalation on leukocyte adhesion molecules, generation of reactive oxygen species, and cytokine release in human blood.

Authors:  H Opdahl; T Haugen; I A Hagberg; T Aspelin; T Lyberg
Journal:  Nitric Oxide       Date:  2000-04       Impact factor: 4.427

Review 2.  Bacterial-induced release of inflammatory mediators by bronchial epithelial cells.

Authors:  O A Khair; R J Davies; J L Devalia
Journal:  Eur Respir J       Date:  1996-09       Impact factor: 16.671

3.  Eosinophil activation by eotaxin--eotaxin primes the production of reactive oxygen species from eosinophils.

Authors:  K Honda; J Chihara
Journal:  Allergy       Date:  1999-12       Impact factor: 13.146

4.  Effects of hyperthermia and tumour necrosis factor on inflammatory cytokine secretion and procoagulant activity in endothelial cells.

Authors:  M F Gnant; E M Turner; H R Alexander
Journal:  Cytokine       Date:  2000-04       Impact factor: 3.861

Review 5.  Chemokines, leukocyte trafficking, and inflammation.

Authors:  T J Schall; K B Bacon
Journal:  Curr Opin Immunol       Date:  1994-12       Impact factor: 7.486

6.  Simultaneous antagonism of interleukin-5, granulocyte-macrophage colony-stimulating factor, and interleukin-3 stimulation of human eosinophils by targetting the common cytokine binding site of their receptors.

Authors:  Q Sun; K Jones; B McClure; B Cambareri; B Zacharakis; P O Iversen; F Stomski; J M Woodcock; C J Bagley; R D'Andrea; A F Lopez
Journal:  Blood       Date:  1999-09-15       Impact factor: 22.113

7.  Na+/K+ ATPase in lower airway epithelium from cystic fibrosis and non-cystic-fibrosis lung.

Authors:  D Peckham; E Holland; S Range; A J Knox
Journal:  Biochem Biophys Res Commun       Date:  1997-03-17       Impact factor: 3.575

8.  Decreased expression of the cystic fibrosis transmembrane conductance regulator protein in remodeled airway epithelium from lung transplanted patients.

Authors:  S Brézillon; H Hamm; M Heilmann; H J Schäfers; J Hinnrasky; T O Wagner; E Puchelle; B Tümmler
Journal:  Hum Pathol       Date:  1997-08       Impact factor: 3.466

9.  CFTR and differentiation markers expression in non-CF and delta F 508 homozygous CF nasal epithelium.

Authors:  F Dupuit; N Kälin; S Brézillon; J Hinnrasky; B Tümmler; E Puchelle
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

10.  Effect of Haemophilus influenzae endotoxin on the synthesis of IL-6, IL-8, TNF-alpha and expression of ICAM-1 in cultured human bronchial epithelial cells.

Authors:  O A Khair; J L Devalia; M M Abdelaziz; R J Sapsford; H Tarraf; R J Davies
Journal:  Eur Respir J       Date:  1994-12       Impact factor: 16.671

View more
  16 in total

1.  Human nasal polyp microenvironments maintained in a viable and functional state as xenografts in NOD-scid IL2rgamma(null) mice.

Authors:  Joel M Bernstein; Stephen P Brooks; Heather K Lehman; Liza Pope; Amy Sands; Leonard D Shultz; Richard B Bankert
Journal:  Ann Otol Rhinol Laryngol       Date:  2009-12       Impact factor: 1.547

2.  Humanized mouse model used to monitor MUC gene expression in nasal polyps and to preclinically evaluate the efficacy of montelukast in reducing mucus production.

Authors:  Joel M Bernstein; Heather Lehman; Maciej Lis; Amy Sands; Gregory E Wilding; Leonard Shultz; Richard Bankert; Libuse Bobek
Journal:  Ann Otol Rhinol Laryngol       Date:  2012-05       Impact factor: 1.547

3.  Plasma RANTES and eotaxin levels are correlated with the severity of chronic rhinosinusitis.

Authors:  Pin-Zhir Chao; Chi-Ming Chou; Chen-Ho Chen
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-01-24       Impact factor: 2.503

4.  Analysis of most common CFTR mutations in patients affected by nasal polyps.

Authors:  Marzena Kostuch; Janusz Klatka; Andrzej Semczuk; Jacek Wojcierowski; Lucas Kulczycki; Jan Oleszczuk
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-06-17       Impact factor: 2.503

5.  Gene-environment interactions between ERCC2, ERCC3, XRCC1 and cadmium exposure in nasal polyposis disease.

Authors:  Rim Khlifi; Pablo Olmedo; Fernando Gil; Boutheina Hammami; Amel Hamza-Chaffai; Ahmed Rebai
Journal:  J Appl Genet       Date:  2016-11-12       Impact factor: 3.240

6.  Interleukin 5, IL6, IL12, IFN-gamma, RANTES and Fractalkine in human nasal polyps, turbinate mucosa and serum.

Authors:  Arild Danielsen; Turid Tynning; Karl A Brokstad; Jan Olofsson; Ake Davidsson
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-02-03       Impact factor: 2.503

7.  [Immunocytochemical detection of caspase 3 in various diseases of human nasal mucosa].

Authors:  R Hirt; F Paulsen; K Neumann; S Knipping
Journal:  HNO       Date:  2009-05       Impact factor: 1.284

8.  Genetic polymorphisms in chronic hyperplastic sinusitis with nasal polyposis.

Authors:  Joel M Bernstein; Jack B Anon; Michael Rontal; Jeffrey Conroy; Chong Wang; Lara Sucheston
Journal:  Laryngoscope       Date:  2009-07       Impact factor: 3.325

9.  Expression of Clara cell 10-kDa protein and trefoil factor family 1 in patients with chronic rhinosinusitis and nasal polyps.

Authors:  Yuanyuan Wang; Zong-Feng Wang; Zhili Zhang; Yi Su
Journal:  Exp Ther Med       Date:  2018-01-09       Impact factor: 2.447

10.  TNF-alpha G/A308 polymorphism association with nasal polyposis in North part of Iran.

Authors:  Masoumeh Faghani; Parvaneh Keshavars; Alireza Sharafshah; Babak Pourgholamali; Farshad Moharami; Shadman Nemati
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-07-12       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.